Global Pharmaceuticals & Biotech Big Green Snowflakes

Ilsung Is

Market Cap: ₩172.1b

Operates as a pharmaceutical company in South Korea.

Humanwell Healthcare (Group)Ltd

Market Cap: CN¥35.8b

Researches, develops, produces, and sells pharmaceutical products in China and internationally.

Shanghai Kaibao PharmaceuticalLtd

Market Cap: CN¥6.5b

Engages in the research, development, production, and sale of modern Chinese medicines primarily in China.

Beijing Tiantan Biological Products

Market Cap: CN¥39.2b

Beijing Tiantan Biological Products Co., Ltd.

Hubei Jumpcan Pharmaceutical

Market Cap: CN¥23.7b

Engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China.

SSY Group

Market Cap: HK$9.6b

An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.

Tibet AIM Pharm

Market Cap: CN¥3.6b

Engages in the research and development, manufacturing, and sale of medical products in China.

Venus Remedies

Market Cap: ₹6.2b

Engages in the pharmaceutical business in India and internationally.

Vikram Thermo (India)

Market Cap: ₹5.1b

Engages in the manufacture, marketing, and export of pharmaceutical excipients and chemicals in India and internationally.

Kopran

Market Cap: ₹8.5b

An integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally.

Neuland Laboratories

Market Cap: ₹185.5b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

Winston Medical Supply

Market Cap: NT$2.0b

Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally.

Shanghai RAAS Blood Products

Market Cap: CN¥45.2b

Engages in the manufacture and sale of blood products in China.

Celltrion

Market Cap: ₩37.2t

A biopharmaceutical company, engages in the development, production, and sale of various therapeutic proteins for the treatment of oncology diseases.

Almirall

Market Cap: €2.4b

Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.

Philadelphia Pharmaceuticals

Market Cap: د.أ11.3m

Develops, manufactures, and markets human pharmaceutical products, cosmetics, and medical devices of various therapeutic categories in Jordan.

Iovance Biotherapeutics

Market Cap: US$796.1m

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.

Basilea Pharmaceutica

Market Cap: CHF 575.5m

A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.

Adcock Ingram Holdings

Market Cap: R10.5b

Engages in the manufacture, marketing, and distribution of healthcare products to private and public sectors in Southern Africa and India.

Marker Therapeutics

Market Cap: US$11.1m

A clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.

Vertex Pharmaceuticals

Market Cap: US$101.8b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

BeOne Medicines

Market Cap: US$35.1b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Haisco Pharmaceutical Group

Market Cap: CN¥65.1b

Researches, develops, manufactures, and sells pharmaceutical products in China.

AprilBioLtd

Market Cap: ₩574.3b

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.

Binh Dinh Pharmaceutical and Medical Equipment

Market Cap: ₫5.0t

Manufactures and trades in pharmaceuticals and medical equipment in Vietnam.

North China Pharmaceutical Company.Ltd

Market Cap: CN¥10.6b

Engages in the research and development, production, and sales of pharmaceutical products in China.

Ever Supreme Bio Technology

Market Cap: NT$13.9b

Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.

Eisai

Market Cap: JP¥1.4t

Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.

Cohance Lifesciences

Market Cap: ₹353.1b

Engages in the contract research, development, and manufacturing of new chemical entity (NCE) based intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs in India, the United States, Europe, and internationally.

Quality Chemical Industries

Market Cap: USh430.9b

Manufactures and sells pharmaceutical drugs in Uganda.

Human Metabolome Technologies

Market Cap: JP¥4.2b

Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan.

Bora Pharmaceuticals

Market Cap: NT$90.8b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

Jilin Province Huinan Changlong Bio-pharmacy

Market Cap: HK$1.2b

Manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China.

Soho Global Health

Market Cap: Rp9.6t

Together with its subsidiaires, operates as a healthcare company in Indonesia.

Mainz Biomed

Market Cap: US$5.8m

Develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe.

aTyr Pharma

Market Cap: US$536.0m

A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.